NCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
Clinical Trials
4 trialsNCT00867672 2016-08-31
DECIDER
University Hospital Freiburg
Phase 2 Completed
NCT00326170 2012-06-15
Phase II 5-Azacytidine Plus VPA Plus ATRA
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00136461 2011-03-10
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Dana-Farber Cancer Institute
Phase 2 Completed